Clive A. Meanwell
2014
In 2014, Clive A. Meanwell earned a total compensation of $5.2M as Chief Executive Officer at Medicines, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $655,937 |
|---|---|
| Option Awards | $1,823,906 |
| Salary | $874,583 |
| Stock Awards | $1,835,505 |
| Other | $3,354 |
| Total | $5,193,285 |
Meanwell received $1.8M in stock awards, accounting for 35% of the total pay in 2014.
Meanwell also received $655.9K in non-equity incentive plan, $1.8M in option awards, $874.6K in salary and $3.4K in other compensation.
Rankings
In 2014, Clive A. Meanwell's compensation ranked 1,486th out of 13,032 executives tracked by ExecPay. In other words, Meanwell earned more than 88.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,486 out of 13,032 | 89th |
Division Manufacturing | 532 out of 4,965 | 89th |
Major group Chemicals And Allied Products | 166 out of 1,690 | 90th |
Industry group Drugs | 131 out of 1,369 | 90th |
Industry Pharmaceutical Preparations | 114 out of 1,042 | 89th |
Source: SEC filing on April 26, 2017.
Meanwell's colleagues
We found four more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2014.